GMED Globus Medical Inc Class A

Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting

Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting
EN
05/10/2020

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Globus Medical Reports Fourth Quarter and Full Year 2025 Results AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: Worldwide net sales were $826.4 million, an increase of 25.7%, or an increase of 24.7% on a constant currency basis.Base business, excluding Nevro, net sales were $726.7 million, an increase of 10.6%, or an increase of 9.4% on a constant currency basis.GAAP net income for ...

February 24, 2026 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Re...

Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Parti...

February 12, 2026 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year...

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over ...

January 7, 2026 1 EN
Free Trial
GMED Globus Medical ...

Globus Medical Inc: 1 director

A director at Globus Medical Inc sold 4,000 shares at 88.850USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

GMED GLOBUS MEDICAL INC CLASS A
12/17/25 December 17, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports Third Quarter 2025 Results

Globus Medical Reports Third Quarter 2025 Results AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025. Worldwide net sales were $769.0 million, an increase of 22.9%, or an increase of 22.3% on a constant currency basisBase business, excluding Nevro, net sales were $669.8 million, an increase of 7.0%, or an increase of 6.5% on a constant currency basisGAAP net income for the quarter was $119.0 millionGAAP diluted earnings per share (“EP...

November 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch